TipRanks

Kevin Tang Insider Profile

60 Followers
Kevin Tang, Ten Percent Owner at Boundless Bio Inc., holds 3.02M shares in Boundless Bio Inc. (Ticker: BOLD), holds 7.08M shares in Fulcrum Therapeutics (Ticker: FULC), holds 13.04M shares in Aurinia Pharmaceuticals (Ticker: AUPH). Most recently, Kevin Tang Bought ― shares of Boundless Bio Inc. on Oct 29, 2026 for an estimated value of $25.70K.
tipranks
Kevin Tang

Kevin Tang
Boundless Bio Inc. (BOLD)
Ten Percent Owner

Ranked #272 out of 109,349 Corporate Insiders

Profitable Transactions

64%
51 out of 80 Profitable Transactions

Average Return

+26.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2T
99.99%
0.01%
<0.01%
<0.01%
<0.01% Others
A breakdown of Kevin Tang's holdings

Insider Roles

Odonate
(ODTC)
CEO, Director, Ten Percent Owner
Aurinia Pharmaceuticals
(AUPH)
CEO, Director, Ten Percent Owner
Fulcrum Therapeutics
(FULC)
Ten Percent Owner
Vanda
(VNDA)
Ten Percent Owner
+4 other positions
Roles that Kevin Tang holds in companies

Most Profitable Insider Trade

Stock:
La Jolla Pharma
(LJPC)
Rating:Informative Buy
Date:Sep 26, 2014 - Sep 26, 2015
Return:+228.40%
The most profitable trade made by Kevin Tang

Kevin Tang's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Boundless Bio Inc.
Oct 29, 2026
Ten Percent Owner
Informative Buy
25.70K
$7.50M
Fulcrum Therapeutics
Jul 20, 2026
Ten Percent Owner
Informative Buy
594.68K
$26.70M
Heron Therapeutics
Oct 07, 2019
Director
Informative Buy
5.00M
$1.71M
Bio Green Med Solution
Feb 27, 2017
Ten Percent Owner
Informative Buy
581.09K
$464.72K
Odonate
Nov 19, 2021
CEO, Director, Ten Percent Owner
Informative Sell
5.72M
$1.92T
Aptevo Therapeutics
Nov 26, 2021
Exit Filing
Informative Sell
10.36M
$0.00
JNCE
Jounce Therapeutics
May 05, 2023
―
Uninformative Sell
9.81M
$18.80K
TCRR
TCR2 Therapeutics
May 30, 2023
―
Informative Buy
86.00K
$6.50M
~RAIN
Rain Oncology
Dec 18, 2023
―
Informative Sell
209.41K
$4.66M
OMIC
Singular Genomics Systems
Sep 18, 2024
―
Informative Buy
1.81M
$7.44M
Aurinia Pharmaceuticals
Jun 02, 2026
CEO, Director, Ten Percent Owner
Informative Buy
12.46M
$224.49M
LJPC
La Jolla Pharma
Dec 01, 2021
―
Informative Sell
1.73M
$59.76M
ASRT
Assertio Therapeutics
―
―
―
$89.71M
ARDMQ
Aradigm
―
―
―
$273.56K
Vanda
Jan 19, 2010
Ten Percent Owner
Informative Sell
589.08K
$11.00M
MTEMQ
Molecular Templates
―
―
―
$82.80K
QCOR
Questcor
―
―
―
―
GEVA
Synageva
―
―
―
―
List of latest transactions for each holding click on a transaction to see Kevin Tang's performance on stock

Kevin Tang insider profile FAQ

What is the percentage of profitable transactions made by Kevin Tang?
The percentage of profitable transactions made by Kevin Tang is 64%.
    What is the average return per transaction made by Kevin Tang?
    The average return per transaction made by Kevin Tang is 26.40%.
      What stocks does Kevin Tang hold?
      Kevin Tang holds: BOLD, FULC, HRTX, BGMS, ODTC, APVO, JNCE, TCRR, ~RAIN, OMIC, AUPH, LJPC, ASRT, ARDMQ, VNDA, MTEMQ, QCOR, GEVA stocks.
        What was Kevin Tang’s latest transaction?
        Kevin Tang latest transaction was an Informative Buy of $25.70K.
          What was Kevin Tang's most profitable transaction?
          Kevin Tang’s most profitable transaction was an Informative Buy of LJPC stock on September 26, 2014. The return on the trade was 228.40%.
            What is Kevin Tang's role in Boundless Bio Inc.?
            Kevin Tang's role in Boundless Bio Inc. is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.